LAVA Therapeutics N.V. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SHAY CAPITAL LLC | 11/14/2025 | 2.55 M | $3.98 M | 100.00% | 9.48% |
| REDMILE GROUP, LLC | 11/14/2025 | 2.07 M | $3.24 M | 0.00% | 7.71% |
| BML CAPITAL MANAGEMENT, LLC | 11/10/2025 | 1.97 M | $3.07 M | 0.00% | 7.33% |
| SANOFI | 11/04/2025 | 1.92 M | $2.99 M | 0.00% | 7.14% |
| MERCK & CO., INC. | 11/12/2025 | 1.15 M | $1.79 M | 0.00% | 4.27% |
| GTS SECURITIES LLC | 11/14/2025 | 200.00 K | $312.00 K | 100.00% | 0.74% |
| RANGELEY CAPITAL, LLC | 11/14/2025 | 165.00 K | $257.40 K | 509.46% | 0.61% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 118.10 K | $184.24 K | 100.00% | 0.44% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 65.00 K | $101.40 K | 0.00% | 0.24% |
| CITADEL ADVISORS LLC | 11/14/2025 | 53.31 K | $83.16 K | 2.90% | 0.20% |
| ROYAL BANK OF CANADA | 11/14/2025 | 44.35 K | $69.00 K | 100.00% | 0.16% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 36.20 K | $56.47 K | 100.00% | 0.13% |
| LEPERCQ DE NEUFLIZE ASSET MANAGEMENT LLC | 11/10/2025 | 31.00 K | $48.36 K | 0.00% | 0.12% |
| JBF CAPITAL, INC. | 11/14/2025 | 23.91 K | $37.30 K | 100.00% | 0.09% |
| XTX TOPCO LTD | 11/14/2025 | 21.73 K | $33.89 K | 100.00% | 0.08% |
| UBS GROUP AG | 11/13/2025 | 15.87 K | $24.76 K | -3.11% | 0.06% |
| EQUITEC PROPRIETARY MARKETS, LLC | 11/26/2025 | 15.40 K | $24.02 K | 100.00% | 0.06% |
| TORNO CAPITAL, LLC | 11/14/2025 | 15.00 K | $23.40 K | 100.00% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 14.17 K | $22.11 K | 0.00% | 0.05% |
| EQUITEC PROPRIETARY MARKETS, LLC | 11/26/2025 | 12.50 K | $19.50 K | 100.00% | 0.05% |
| JANE STREET GROUP, LLC | 11/14/2025 | 12.50 K | $19.50 K | 100.00% | 0.05% |
| TSFG, LLC | 11/04/2025 | 400 | $1.00 K | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 400 | $636 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 300 | $468 | 0.00% | 0.00% |
| SMALLWOOD WEALTH INVESTMENT MANAGEMENT, LLC | 10/17/2025 | 26 | $40 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BRUCE & CO., INC. | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PATHWAY FINANCIAL ADVISORS LLC | 10/10/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
LAVA Therapeutics N.V. institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of LAVA Therapeutics N.V.. The most heavily invested institutionals were:
Shay Capital LLC: 2.55 M
Redmile Group, LLC: 2.07 M
BML Capital Management, LLC: 1.97 M
Sanofi: 1.92 M
Merck & Co., Inc.: 1.15 M
GTS SECURITIES LLC: 200,000
38.39% of LAVA Therapeutics N.V. stock is owned by institutional investors.
Institutional investors have bought a total of 10.33 M shares in the last 24 months. This purchase volume represents approximately $16.52 M in transactions.